Searched for
ASTELLAS PHARMA INC
Zydus settles US Mirabegron patent dispute with Astellas for $120 millionZydus Lifesciences and its US subsidiary have settled patent litigation with Astellas Pharma over Astellas' Myrbetriq. Zydus will pay Astel...- Lupin clears Mirabegron patent dispute with Astellas in $90 million deal, secures US sales continuityDrugmaker Lupin has settled a patent infringement dispute with Astellas Pharma over its Mirabegron product for $90 million. The agreement i...
- Pfizer buys Seagen for $43B, boosts access to cancer drugsThe deal announced Monday will combine Seagen's technology with Pfizer's scale and strength, Pfizer CEO Albert Bourla said in a statement. ...
- Heavyweights pull Nikkei lower, Topix gains on drugmakers' boostNikkei inched down 0.2 per cent to close at 28,963.56, while the Topix edged up 0.1 per cent at 1,962.65.
- Japan stocks end lower after Tokyo goes on highest virus alertTokyo's daily tally of new cases set for a record high of more than 500 while its governor warned of a worse scenario unless action is take...
- Lupin, Concord Biotech get USFDA nod for generic immunosuppressant capsulesIn alliance with Concord Biotech, the company has received approval from the United States Food and Drug Administration (USFDA) to market T...
- Glenmark Pharma gets USFDA nod for Tacrolimus capsulesGlenmark Pharmaceuticals Inc, USA, has been granted final approval by the United States Food and Drug Administration (USFDA) for Tacrolimus...
- Japan stocks hit highest in more than 3 months on economic hopesThe Nikkei index ended 1.19% higher at 22,325.61 points after earlier rising to its highest level since Feb. 26. Industrial and technology ...
- Strides Pharma suspends sale of Ranitidine tab in USIn a regulatory filing, the company said it has received an Information Request from the USFDA to provide test data related to NDMA impurit...
- Strides Pharma Science arm gets USFDA nod for drug to treat overactive bladderThe approved product is a generic version of Vesicare tablets of Astellas Pharma US, Inc.
- Alembic Pharma gets USFDA nod for overactive bladder treatment drugThe company has received approval from the USFDA for its abbreviated new drug application (ANDA) Solifenacin Succinate tablets in the stren...
- Glenmark Pharma's overactive bladder drug gets USFDA nodAccording to IMS Health April 2017 sales data, the market for Vesicare tablets, 5 mg and 10 mg, saw annual sales of approximately USD 1.1 b...
- Lupin arm in pact to distribute anti-depressant drug in JapanLupin President Dr. Fabrice Egros said the Astellas agreement reinforces Kyowa's transition toward a hybrid pharmaceutical specialty care c...
- Glenmark launches generic Hydrocortisone Butyrate cream in USThe company's current portfolio consists of 90 products authorised for distribution in the US market and 56 ANDA's pending approval before ...
- Glenmark Generics Inc files law suit to enforce licence pactThe agreement is with Triax Pharmaceuticals, Astellas Pharma Europe BV and Astellas Pharma International BV.
- Glenmark gets USFDA nod for skin infections creamGlenmark Pharmaceuticals received approval from USFDA for its generic Hydrocortisone Butyrate Cream used for treating skin infections.
- Glenmark settles patent suit in US over skin infection creamGlenmark Pharma said it has entered into a agreement with Triax and Astellas to resolve a patent infringement case in the US.
- Get rich by betting a takeover rumour is wrongWhile stocks that were the subject of takeover speculation initially jumped 2.9%, betting on declines yielded average profits of 1.2% in th...
- Astellas Pharma Q1 profit falls on R&D costsAstellas Pharma Inc Japan's second-largest drug maker, said on Friday its quarterly operating profit fell 5 percent on higher research and ...
- GSK enters into agreement with Japan-based Astellas PharmaDrug firm GlaxoSmithkline Pharmaceuticals on Monday said it has enter into a collaboration with the Japan-based Astellas Pharma Inc for sel...
Load More
